Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 3

Session: Using Novel Antimicrobial Therapies in Transplant ID: Preserving the Pipeline

Rolling out New GNR Agents in Transplant: Case Use with Cefiderocol

Friday, October 1, 2021
4:15 PM - 5:30 PM EDT
Participants should be aware of the following financial/non-financial relationships:
Erin K. McCreary, PharmD, BCPS, BCIDP: AbbVie (Individual(s) Involved: Self): Consultant; Cidara (Individual(s) Involved: Self): Consultant; Entasis (Individual(s) Involved: Self): Consultant; Ferring (Individual(s) Involved: Self): Consultant; Infectious Disease Connect, Inc (Individual(s) Involved: Self): Director of Stewardship Innovation, Other Financial or Material Support; Merck (Individual(s) Involved: Self): Consultant; Shionogi (Individual(s) Involved: Self): Consultant; Summit (Individual(s) Involved: Self): Consultant

    Speaker(s)

  • Erin K. McCreary, PharmD, BCPS, BCIDP

    Clinical Assistant Professor, Director of Infectious Diseases Improvement and Clinical Research Innovation
    University of Pittsburgh, UPMC
    Pittsburgh, PA, United States

    AbbVie (Individual(s) Involved: Self): Consultant; Cidara (Individual(s) Involved: Self): Consultant; Entasis (Individual(s) Involved: Self): Consultant; Ferring (Individual(s) Involved: Self): Consultant; Infectious Disease Connect, Inc (Individual(s) Involved: Self): Director of Stewardship Innovation, Other Financial or Material Support; Merck (Individual(s) Involved: Self): Consultant; Shionogi (Individual(s) Involved: Self): Consultant; Summit (Individual(s) Involved: Self): Consultant